ELV Stock Elevance Health, Inc.
US · NYSELast in our picks 2026-10-25 — not in the current list; analysis below is from that screen
Depressed valuation offers recovery potential as medical-cost pressure normalizes.
Future value: $456.00 (+3.65%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Valuation recovery setup with expected medical-loss normalization.
- ▸Above 50-day MA (+7.82%)
- ▸Above 200-day MA — long-term uptrend
- ▸Near 52-week high (93.9% of range) — strength
Is ELV a buy right now?
Trend: ELV is trading above the 50-day average (+5.54%), RSI 46 — neutral momentum, with a 3-month return of +11.82%.
Valuation & quality: Elevance Health, Inc. trades on a trailing P/E of 18.3, forward P/E 14.2, PEG 1.35, price-to-book 2.09; fundamentals show net margin 2.5%, return on equity 11.5%, revenue growth 1.4% year on year.
Analyst consensus: 21 analysts have a mean 12-month price target of $482.38 (+11.8% vs the last close; range $406.00 – $523.00), consensus rating “buy”.
Income: trailing dividend yield 1.56%.
Our screen: STRONG BUY (score 4) — Depressed valuation offers recovery potential as medical-cost pressure normalizes.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -8.50% | +28.60% | +4.50% | -1.60% | -2.80% | +4.40% | -0.90% | +10.90% |
Fundamentals
Analyst price target
Technical signals
About Elevance Health, Inc.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
Sector: Healthcare · Industry: Healthcare Plans · United States · 96,129 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.